2:14 Health Canada reviews safety of breastfeeding drug domperidone Domperidone blocks some of the body’s dopamine receptors, called D2 receptors. Dopamine is a neurotransmitter, but it’s not just ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

Adult: Oral- Nausea and vomiting- 10-20 mg 4-8 hourly. Max: 80 mg/day. Non ulcer dyspepsia- 10-20 mg 3 times/day and at night. Migraine- 20 mg 4 hourly. Max: 4 doses/24 hour. Rectal- Nausea and ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Jamie Robinson and ...

2:01 ‘I felt like a zombie’: Health Canada launches domperidone review as patients come forward After giving birth to her son on April 18, 2021, 38-year-old Jennifer Ferger in Victoria, B.C., had ...

This week, Health Canada publicly confirmed that it is reviewing the safety of domperidone, a drug used to treat gastrointestinal symptoms that has also been prescribed off-label to improve breast ...

European Union (EU) drug regulators announced yesterday that they have begun a review of domperidone, an antiemetic, because of concerns about adverse cardiac events, including QT prolongation and ...

The European Medicines Agency's (EMA's) Coordination Group for Mutual Recognition and Decentralised Procedures (CMDh) has endorsed recommendations to restrict the use of domperidone-containing ...